This heterogeneity in dependency on different PI3K-AKT-mTOR signalling nodes in DLBCL suggests whilst the PI3K-AKT signalling pathway is critically important, the mechanism may vary between cell lines [7, 29]. Here, AKT1 is linked to diffuse large B-cell lymphoma.